NEW YORK, Feb. 08, 2023 — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for rexlemestrocel-L in the treatment of chronic low back pain (CLBP) associated with disc degeneration, in combination with hyaluronic acid (HA) as delivery agent for injection into the lumbar disc. [Read more…]
Immunotherapy company iPSirius appoints Dr. Stephen Sullivan as Chief Operating Officer
iPSirius appoints COO to oversee human trials with allogeneic cancer vaccines made from stem cells
Paris, France, 10th February 2023 – iPSirius, a pre-clinical biotech company in the immuno-oncology field, is pleased to announce the appointment of a new COO, Dr. Stephen Sullivan. Dr. Sullivan, previously the program manager at the Global Alliance for iPSC therapies, is a pluripotent stem cell manufacturing expert. He will oversee the day-to-day operations of the company and the first in-human trials for the company’snovel therapeutic, IPVAC. [Read more…]
Do Stem Cell Treatments For Arthritis Work? Get the Facts.
Can stem cell treatments for arthritis bring relief to those suffering from the disease?
From the dawn of history to present day, the swelling and aching of joints rank as one of the most troublesome indicators of age. As connective tissue breaks down over time, the result is stiffening, pain and immobility. While some are luckier than others, few seem to escape it entirely – which is why stem cell treatment for arthritis is intriguing to so many. [Read more…]
List of U.S. FDA Approved Cell and Gene Therapy Products (27)
Today, researchers and clinicians are under great pressure to develop therapies capable of reversing or significantly impacting the progression of disease. In recent years, the arrival of the cell and gene therapy industries have introduced the possibility of providing transformative, durable and potentially curative outcomes for a diverse range of life-threatening conditions, as well as injuries, degenerative diseases, genetic disorders, and cancers. [Read more…]
Induced Pluripotent Stem Cell (iPSC) Industry Trends Dominating in 2023
Induced pluripotent stem cells (iPS cells or iPSCs) are laboratory-made pluripotent stem cells that are produced using non-controversial adult cells. They are derived from somatic cells through reprogramming and turning on the expression of specific pluripotency genes. This reprogramming can be achieved using different techniques with varying efficiencies. [Read more…]
- « Previous Page
- Next Page »